Skip to content
Menu

Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3

Benzinga Newsdesk 1 week ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.

Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.

Read at benzinga.com

← All stock news